External Beam Radiation Therapy (EBRT)
Sponsors
Massachusetts General Hospital, Case Comprehensive Cancer Center, Spanish Oncology Genito-Urinary Group, Melanoma and Skin Cancer Trials Limited, ImmunityBio, Inc.
Conditions
Adenocarcinoma of the RectumBladder CancerHigh-risk Prostate CancerMetastatic Merkel Cell CarcinomaProstate Cancer (Adenocarcinoma)Prostate Cancer Patients Treated by RadiotherapyRadiation ToxicityRectal Cancer
Phase 1
Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer
CompletedNCT00307736
Start: 2006-05-31End: 2011-07-31Updated: 2017-05-10
Targeted Therapy and Avelumab in Merkel Cell Carcinoma
Active, not recruitingNCT04261855
Start: 2020-10-08End: 2027-12-01Target: 19Updated: 2026-03-27
Phase 2
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy
CompletedNCT01487954
Start: 2010-05-31End: 2012-11-30Updated: 2015-06-18
Efficacy of Atezolizumab Concurrent With Radiotherapy in Patients With Muscle-invasive Bladder cáncer
Active, not recruitingNCT04186013
Start: 2019-09-18End: 2027-05-31Target: 39Updated: 2022-10-26
Immunotherapy With N 803, ETBX-071, and M-CENK in Combination With Radiation for Participants With High-Risk Prostate Cancer.
Not yet recruitingNCT06765954
Start: 2025-06-01End: 2031-06-30Target: 20Updated: 2025-05-06
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
RecruitingNCT07332000
Start: 2025-10-30End: 2026-08-01Target: 45Updated: 2026-03-20